Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas N Nassar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|March 13, 2020
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer modelsAnjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Leukemia|October 29, 2021
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemiaShailaja Hegde, Anjelika Gasilina, Mark Wunderlich, et al.
American Journal of Human Genetics|November 13, 2020
VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking DefectsKatie G Seu, Lisa R Trump, Sana Emberesh, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|March 13, 2020
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer modelsAnjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Leukemia|October 29, 2021
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemiaShailaja Hegde, Anjelika Gasilina, Mark Wunderlich, et al.
American Journal of Human Genetics|November 13, 2020
VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking DefectsKatie G Seu, Lisa R Trump, Sana Emberesh, et al.
Pageof 1